Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Antibodies Market to Grow at a CAGR of 12.5%: Global Industry Analysis and Opportunity Assessment 2016-2026 - Research and Markets

Research and Markets
Posted on: 19 Aug 16

Research and Markets has announced the addition of the "Antibodies Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.

This report offers a 10-year forecast on the global market for antibodies between 2016 and 2026. The global antibodies market is expected to witness a robust CAGR of 12.5% over the forecast period. The study demonstrates market dynamics that are expected to influence the current environment and future status of the global antibodies market over the forecast period.

The primary objective of this report is to offer updates on trends, drivers, restraints, value forecasts, and opportunities for manufacturers operating in the global antibodies market.

Global demand for antibodies is increasing with growing burden of chronic illnesses such as cancer, autoimmune disorders and others. Developed markets such as the U.S. and Europe are witnessing increasing demand for antibody-based drugs due to rising demand for better treatment options.

To understand and analyse the market, the report is categorically split into four sections, viz. market analysis by drug type, end user, indication, and regions. The report analyses the global antibodies market in terms of value (US$ Mn).

Scope of the Report

The global antibodies market is segmented on the basis of

- Drug type

- End User

- Disease Indication

- Region

Drug types covered in the report include:

- Monoclonal antibodies

- Polyclonal antibodies

- Antibody drug conjugates

The end users covered in this report are:

- Hospitals

- Long-term care facilities

- Research institutes

The indications covered in the report include:

- CNS Disorders

- Cardiovascular Diseases

- Cancer

- Autoimmune disorders

Key players in the market include

- AbbVie Inc.

- Amgen Inc.

- Biogen Inc.

- Bristol-Myers Squibb Company

- Eli Lilly and Co.

- F. Hoffmann-La Roche Ltd.

- Johnson & Johnson Services Inc.

- Novartis AG

- Sanofi

- Takeda Pharmaceutical Company Limited

For more information about this report visit

Related Topics: Biopharmaceuticals

View source version on

Business Wire

Last updated on: 19/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.